Bacitracin
NDC Package 68071-4285-3

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Bacitracin is a medication an antibiotic used to treat certain bacterial eye infections. Marketed by Nucare Pharmaceuticals,inc., this product is identified by NDC 68071-4285 and is authorized under FDA application M004.

Identification & Billing

NDC Package Code
68071-4285-3
Package Description
28 g in 1 BOX
Product Code
68071-4285
11-Digit Billing Format
68071428503

Clinical Specifications

Proprietary Name
Bacitracin
Dosage Form
-
Usage Information
This medication is an antibiotic used to treat certain bacterial eye infections. It works by stopping the growth of bacteria. This medication treats only bacterial eye infections. It will not work for other types of eye infections. Unnecessary use or overuse of any antibiotic can lead to its decreased effectiveness.

Regulatory & Marketing

Labeler Name
Nucare Pharmaceuticals,inc.
FDA Application #
M004
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
06-20-2011
End Marketing Date
12-31-2020
Listing Expiration
12-31-2020
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 68071-4285-3 identifies a specific commercial package of 28 g in 1 box of Bacitracin, labeled by Nucare Pharmaceuticals,inc.. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Nucare Pharmaceuticals,inc. on June 20, 2011. The current certification is valid through December 31, 2020.

What are the primary indications for this medication?

This medication is an antibiotic used to treat certain bacterial eye infections. It works by stopping the growth of bacteria. This medication treats only bacterial eye infections. It will not work for other types of eye infections. Unnecessary use or overuse of any antibiotic can lead to its decreased effectiveness.

How is this Nucare Pharmaceuticals,inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 68071428503. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
68071-4285-3
11-Digit CMS (5-4-2)
68071-4285-03

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.